LncRNA XXYLT1-AS2, highly expressed in HCC plasma, promotes tumor growth by inhibiting autophagy and enhancing proliferation, migration, and invasion of HCC cells, through the degradation of TFEB via the ubiquitin proteasome pathway. This evidence concerns the gene TFEB and hepatocellular carcinoma.